Pediatricians are urged to follow 2024 guidelines amid ACIP upheaval, vaccine hesitancy, and access issues as children head ...

Elizabeth Reichert, PhD, shared practical tips for pediatricians to help families monitor teen media use and recognize early signs of anxiety.

An expert discusses practical strategies for assessing atopic dermatitis severity, highlighting simple yet effective tools such as the Investigator Global Assessment (IGA) scale, palm-based body ...

An expert discusses advancements in the management of atopic dermatitis, emphasizing early recognition, updated nonsteroidal treatments, accurate differential diagnosis, and the importance of ...

An expert discusses the benefits and risks of topical corticosteroids (TCS) and calcineurin inhibitors in atopic dermatitis (AD) treatment, highlighting patient concerns about long-term adverse ...

An expert discusses the formal diagnostic criteria and diverse clinical presentations of atopic dermatitis, emphasizing patient-centered assessment, challenges in distinguishing it from similar ...

On July 30, 2025, AbbVie announced positive and topline data from the phase 3 UP-AA clinical program (NCT06012240), in which upadacitinib (Rinvoq) (15 mg and 30 mg) demonstrated that 44.6% and 54.3% ...

On July 28, 2025, the FDA approved PTC Therapeutics' sepiapterin (Sephience) to treat adult and pediatric patients with phenylketonuria (PKU), including all age groups and the full spectrum of disease ...

Suzanne Hollander, MS, RD, LDN and Timothy Tramontana, MD offer thoughts on the newly FDA-approved sepiapterin for PKU. On July 28, 2025, the FDA approved PTC Therapeutics' sepiapterin (Sephience) to ...

The American Academy of Pediatrics (AAP), an organization made up of more than 67,000 pediatricians, pediatric medical sub-specialists, and surgical specialists, has released its influenza vaccine ...

The FDA has approved avatrombopag and new sprinkle formulation for children ≥1 year with chronic ITP, offering an oral, food-flexible treatment option.